121 related articles for article (PubMed ID: 7022279)
1. Re-appraising the potential of naringin for natural, novel orthopedic biotherapies.
Yu KE; Alder KD; Morris MT; Munger AM; Lee I; Cahill SV; Kwon HK; Back J; Lee FY
Ther Adv Musculoskelet Dis; 2020; 12():1759720X20966135. PubMed ID: 33343723
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of BDNF concentration and restoration of the hypothalamic-pituitary-adrenal axis accompany reduced depressive-like behaviour in stressed ovariectomised rats treated with either Tualang honey or estrogen.
Al-Rahbi B; Zakaria R; Othman Z; Hassan A; Ahmad AH
ScientificWorldJournal; 2014; 2014():310821. PubMed ID: 24550703
[TBL] [Abstract][Full Text] [Related]
3. Changes in aquaporin (AQP)2 and AQP3 expression in ovariectomized rat urinary bladder: potential implication of water permeability in urinary bladder.
Kim SO; Song SH; Hwang EC; Oh KJ; Ahn K; Jung SI; Kang TW; Kwon D; Park K; Ryu SB
World J Urol; 2012 Apr; 30(2):207-12. PubMed ID: 21479884
[TBL] [Abstract][Full Text] [Related]
4. Obstetrics and gynecology-important advances in clinical medicine: comparative risks of osteoporosis and endometrial cancer.
Davidson BJ
West J Med; 1983 Oct; 139(4):516-7. PubMed ID: 18749451
[No Abstract] [Full Text] [Related]
5. Therapeutic Issues in Turner's Syndrome.
Conte FA; Grumbach MM
West J Med; 1982 Jul; 137(1):61-2. PubMed ID: 18749150
[No Abstract] [Full Text] [Related]
6. Postmenopausal osteoporosis.
Stevenson JC; Whitehead MI
Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):585-8. PubMed ID: 6819027
[No Abstract] [Full Text] [Related]
7. Guidelines for community menopausal clinics.
Craig GM
Br Med J (Clin Res Ed); 1983 Jun; 286(6383):2033-6. PubMed ID: 6409218
[No Abstract] [Full Text] [Related]
8. Pharmacokinetic considerations in the use of newer transdermal formulations.
Ridout G; Santus GC; Guy RH
Clin Pharmacokinet; 1988 Aug; 15(2):114-31. PubMed ID: 3064951
[TBL] [Abstract][Full Text] [Related]
9. Estrogen replacement therapy: indications and complications.
Judd HL; Meldrum DR; Deftos LJ; Henderson BE
Ann Intern Med; 1983 Feb; 98(2):195-205. PubMed ID: 6824255
[TBL] [Abstract][Full Text] [Related]
10. Estrogen replacement therapy.
Judd HL; Cleary RE; Creasman WT; Figge DC; Kase N; Rosenwaks Z; Tagatz GE
Obstet Gynecol; 1981 Sep; 58(3):267-75. PubMed ID: 7022279
[TBL] [Abstract][Full Text] [Related]
11. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
12. Estrogens for the menopause. Maximizing benefits, minimizing risks.
Seller JC
Postgrad Med; 1977 Sep; 62(3):73-9. PubMed ID: 197509
[TBL] [Abstract][Full Text] [Related]
13. Use of progestogens in postmenopausal women.
Gambrell RD
Int J Fertil; 1989; 34(5):315-21. PubMed ID: 2571591
[TBL] [Abstract][Full Text] [Related]
14. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
Berger GS; Fowler WC
J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
